What is the regimen and suitability of Slynd (drospirenone) for contraception?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Slynd (Drospirenone) for Contraception: Regimen and Suitability

Slynd (drospirenone-only pill) is taken daily with a regimen of 24 active pills followed by 4 inactive pills, and provides effective contraception without estrogen while maintaining a favorable bleeding profile compared to other progestin-only pills. 1, 2

Regimen and Administration

  • Slynd contains 4 mg of drospirenone (DRSP), a progestin-only pill that should be taken once daily 1, 3
  • The regimen consists of 24 active pills followed by 4 inactive pills (24/4 regimen), which helps improve bleeding control compared to traditional progestin-only pills 1, 3
  • Unlike traditional progestin-only pills that require strict timing, Slynd maintains efficacy even with a missed pill due to drospirenone's long half-life of 30-34 hours 4, 3
  • Slynd should be started on the first day of menstruation or on the first Sunday after the onset of menstruation 5

Mechanism and Efficacy

  • Drospirenone works primarily by inhibiting ovulation, unlike traditional progestin-only pills that work mainly by thickening cervical mucus 1, 3
  • The 4 mg drospirenone dose maintains plasma estradiol levels at early follicular phase levels, avoiding hypoestrogenism while still providing effective contraception 4, 3
  • Clinical studies have demonstrated high contraceptive effectiveness with a favorable bleeding pattern 3
  • Ovulation inhibition is maintained even with scheduled 24-hour delays in pill intake, providing more flexibility than traditional progestin-only pills 3, 2

Advantages and Suitability

  • Slynd is suitable for women who have contraindications to estrogen-containing contraceptives 1
  • The drospirenone in Slynd has antimineralocorticoid properties that can help prevent water retention and weight gain often associated with other hormonal contraceptives 6, 7
  • Slynd provides more flexibility for delayed or missed pills while maintaining efficacy compared to other progestin-only pills 2
  • It offers a more favorable bleeding profile compared with previously available progestin-only pills 2
  • Drospirenone has antiandrogenic properties that may benefit women with androgen-related conditions such as acne 6, 7

Safety Considerations

  • Slynd is contraindicated in women with renal impairment, adrenal insufficiency, or hepatic disease 5
  • Unlike combined hormonal contraceptives, progestin-only pills like Slynd do not increase the risk of venous thromboembolism (VTE) 1
  • Caution should be used in patients taking medications that may increase serum potassium due to drospirenone's antimineralocorticoid properties 5
  • Progestin-only contraceptives generally have a very good safety profile with few contraindications 4, 3

Special Populations

  • Slynd is appropriate for women with a history of migraine headaches who cannot use estrogen-containing contraceptives 1, 6
  • It may be beneficial for women with premenstrual symptoms due to drospirenone's antimineralocorticoid and antiandrogenic properties 6, 7
  • Safety and efficacy have been established for women who have reached menarche, but use before menarche is not indicated 5
  • Slynd may be particularly suitable for breastfeeding women, as the amount of drospirenone transferred to breast milk is minimal (approximately 0.1% of maternal dose) 5

Common Pitfalls and Practical Considerations

  • If a pill is missed, it should be taken as soon as remembered, and the next pill should be taken at the regular time 1
  • If more than one pill is missed, additional contraception (such as condoms) should be used for 7 days 1
  • Patients should be informed that breakthrough bleeding may occur, especially during the first few months of use 3
  • Medications that induce liver enzymes (such as rifampin, certain anticonvulsants) may decrease the effectiveness of Slynd 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

New Contraception Update - Annovera, Phexxi, Slynd, and Twirla.

Current obstetrics and gynecology reports, 2022

Research

The drospirenone (DRSP)-only pill: clinical implications in the daily use.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2023

Research

Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literature.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2020

Research

YAZ and the novel progestin drospirenone.

The Journal of reproductive medicine, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.